I promise

"I promise, Suzy... Even if it takes the rest of my life." -Nancy G. Brinker, Founder of Susan G. Komen for the Cure

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Thursday, September 20, 2012

Triple Negative Breast Cancer Foundation Introduces "(Un)Common Knowledge", A Webinar Series

This October, in honor of breast cancer awareness month, Triple Negative Breast Cancer Foundation launches (Un)common Knowledge, a Webinar series featuring perspectives on triple negative breast cancer.
This series will be audience-driven, crafted in response to your most pressing questions, which you will have an opportunity to submit in advance. Raise your hand and join us!


Meet our first (Un)Common Knowledge Presenter - Patricia Prijatal
Oct 16, 2012 at 1 PM (ET)
After her diagnosis of hormone-negative breast cancer in 2006, health writer and journalism professor Patricia Prijatel started investigating the disease: how it occurs, how it's treated, and how to keep it from recurring. She found that much of the research on breast cancer, and much of what was written in the popular media, focused on the more common form, hormone-positive. Yet, as she dug through medical journals, she learned that research was just starting on a newly defined disease, triple-negative breast cancer. Research on TNBC was in its infancy, having started in 2005.
Believing that she was learning things that might help other women, Pat began writing a blog, Positives About Negative, to share her knowledge. It became clear that nobody else was writing about TNBC, so in 2008, she began writing a book. Because of her academic background, she knew how to read and interpret research reports. Because of her background in journalism, she knew how to translate that research into everyday language. And because of her background with hormone-negative breast cancer, she knew what women wanted and needed-information, perspective, clarity, and hope.
It took her four years of poring through hundreds of research studies to produce Surviving Triple-Negative Breast Cancer.

WE WILL BE ACCEPTING QUESTIONS FOR PATRICIA THROUGH SEPTEMBER 24, 2012.
Please email questions to knowledge@tnbcfoundation.org. Questions that are succinct, and apply to more than one individual have a better chance of being included, as it may not be possible to address e
http://www.tnbcfoundation.org/uncommonknowledge_prijatel.htm (click to link)

Total Pageviews



"click image to link"